A detailed history of Russell Investments Group, Ltd. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 232,239 shares of PTCT stock, worth $9.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
232,239
Previous 281,100 17.38%
Holding current value
$9.84 Million
Previous $8.6 Million 0.23%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$30.39 - $37.66 $1.48 Million - $1.84 Million
-48,861 Reduced 17.38%
232,239 $8.62 Million
Q2 2024

Aug 08, 2024

SELL
$24.69 - $40.12 $510,836 - $830,082
-20,690 Reduced 6.86%
281,100 $8.6 Million
Q1 2024

May 08, 2024

BUY
$24.15 - $31.95 $2.67 Million - $3.54 Million
110,670 Added 57.91%
301,790 $8.78 Million
Q4 2023

Feb 05, 2024

SELL
$18.07 - $29.37 $529,794 - $861,099
-29,319 Reduced 13.3%
191,120 $5.27 Million
Q3 2023

Nov 13, 2023

BUY
$22.41 - $41.99 $690,295 - $1.29 Million
30,803 Added 16.24%
220,439 $4.94 Million
Q2 2023

Aug 10, 2023

SELL
$40.4 - $59.1 $2.03 Million - $2.97 Million
-50,280 Reduced 20.96%
189,636 $7.71 Million
Q1 2023

May 09, 2023

SELL
$38.16 - $48.86 $216,100 - $276,694
-5,663 Reduced 2.31%
239,916 $11.6 Million
Q4 2022

Feb 08, 2023

BUY
$33.53 - $54.79 $318,434 - $520,340
9,497 Added 4.02%
245,579 $9.37 Million
Q3 2022

Nov 04, 2022

SELL
$41.85 - $53.85 $454,198 - $584,434
-10,853 Reduced 4.4%
236,082 $11.8 Million
Q2 2022

Jul 29, 2022

BUY
$25.6 - $45.23 $715,366 - $1.26 Million
27,944 Added 12.76%
246,935 $9.89 Million
Q1 2022

May 05, 2022

SELL
$33.33 - $44.6 $828,617 - $1.11 Million
-24,861 Reduced 10.2%
218,991 $8.17 Million
Q4 2021

Jan 21, 2022

BUY
$35.36 - $41.86 $794,256 - $940,259
22,462 Added 10.15%
243,852 $9.71 Million
Q3 2021

Nov 08, 2021

BUY
$37.01 - $44.74 $1.59 Million - $1.92 Million
43,000 Added 24.1%
221,390 $8.24 Million
Q2 2021

Aug 04, 2021

BUY
$37.95 - $49.37 $3.55 Million - $4.62 Million
93,674 Added 110.57%
178,390 $7.54 Million
Q1 2021

May 10, 2021

BUY
$46.8 - $68.92 $896,313 - $1.32 Million
19,152 Added 29.21%
84,716 $4.01 Million
Q4 2020

Feb 08, 2021

SELL
$47.96 - $67.64 $732,732 - $1.03 Million
-15,278 Reduced 18.9%
65,564 $4 Million
Q3 2020

Nov 09, 2020

SELL
$45.41 - $57.07 $660,034 - $829,512
-14,535 Reduced 15.24%
80,842 $3.78 Million
Q2 2020

Aug 05, 2020

BUY
$42.56 - $54.98 $849,497 - $1.1 Million
19,960 Added 26.47%
95,377 $4.84 Million
Q1 2020

May 06, 2020

BUY
$32.37 - $59.36 $30,039 - $55,086
928 Added 1.25%
75,417 $3.36 Million
Q4 2019

Jan 29, 2020

BUY
$32.22 - $50.07 $518,355 - $805,526
16,088 Added 27.55%
74,489 $3.58 Million
Q3 2019

Nov 01, 2019

BUY
$33.82 - $48.17 $1.65 Million - $2.35 Million
48,879 Added 513.33%
58,401 $1.98 Million
Q3 2017

Nov 07, 2017

BUY
$16.81 - $21.61 $160,064 - $205,770
9,522
9,522 $191,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.03B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.